NASDAQ:PRCT PROCEPT BioRobotics Q3 2026 Earnings Date & Estimates $19.96 -0.07 (-0.35%) Closing price 04:00 PM EasternExtended Trading$19.50 -0.46 (-2.32%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. PROCEPT BioRobotics is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from PROCEPT BioRobotics in Q3 2026PROCEPT BioRobotics is expected to post earnings of -$0.3895 per share on revenue of $100.52 million. In the same quarter a year earlier PROCEPT BioRobotics reported -$0.38 per share on revenue of $83.33 million. PROCEPT BioRobotics last reported on August 4, 2026, posting -$0.47 per share and missing the -$0.4619 consensus estimate. PROCEPT BioRobotics has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.3895Expected Revenue$100.52 millionPrior-Year EPS-$0.38Prior-Year Revenue$83.33 millionExpected Revenue Growth+20.6%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.47 (Missed by -$0.0081)Last Quarter Revenue$94.50 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report PROCEPT BioRobotics Q3 2026 Earnings FAQ When does PROCEPT BioRobotics report Q3 2026 earnings? PROCEPT BioRobotics (NASDAQ:PRCT) is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is PROCEPT BioRobotics' Q3 2026 earnings call? PROCEPT BioRobotics' Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for PROCEPT BioRobotics? Analysts expect PROCEPT BioRobotics to post earnings of -$0.3895 per share for Q3 2026. How much revenue is PROCEPT BioRobotics expected to report? The consensus revenue estimate for PROCEPT BioRobotics is $100.52 million for Q3 2026. PROCEPT BioRobotics Earnings HeadlinesFinancial Contrast: PROCEPT BioRobotics (NASDAQ:PRCT) versus Stryker (NYSE:SYK)October 23 at 4:15 AM | americanbankingnews.comPROCEPT BioRobotics: Compelling Bet On Aquablation's GrowthOctober 22 at 11:54 PM | seekingalpha.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.October 23 at 1:00 AM | Investors Alley (Ad)PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Stock Has Average Price Target of $25.50 According to AnalystsOctober 20 at 3:59 AM | americanbankingnews.comPROCEPT BioRobotics Corp (PRCT) Shares Surge 4.0% -- What GF Score of 71 Tells InvestorsOctober 19, 2026 | gurufocus.comPROCEPT BioRobotics (NASDAQ:PRCT) vs. Rockwell Medical (NASDAQ:RMTI) Financial SurveyOctober 17, 2026 | americanbankingnews.comSee More PROCEPT BioRobotics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PROCEPT BioRobotics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PROCEPT BioRobotics and other key companies, straight to your email. Email Address About PROCEPT BioRoboticsPROCEPT BioRobotics (NASDAQ:PRCT) is a medical technology company focused on developing and commercializing robotic solutions for the treatment of benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate that can cause urinary symptoms. The company’s technology is designed to provide a minimally invasive alternative to conventional surgical procedures. Its primary product is the AquaBeam Robotic System, which uses image guidance, robotic assistance and a high-velocity waterjet to remove targeted prostate tissue. The system is intended to support a consistent, anatomically guided procedure while preserving surrounding tissue and structures. PROCEPT has also developed software and related technologies to support treatment planning and delivery. Founded in 2007, PROCEPT BioRobotics received U.S. Food and Drug Administration clearance for its AquaBeam system in 2017. The company serves hospitals, health systems and urology practices in the United States and has expanded commercialization internationally, including in select European and other global markets. Its leadership has included President and Chief Executive Officer Reza Malekzadeh.View PROCEPT BioRobotics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery TestSpotify Soars After Earnings as the Company Touts AI Benefits and Moderating CostsPalantir's Next Big Test Isn't a Partnership—It's the NumbersKinder Morgan's $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings BeatCapital One Earnings: After a Double Beat the Rally Is OnTractor Supply's Q3 Beat Plants the Seeds for a Stock ReboundWD-40 Could Reward Patient Investors—Here's Why Upcoming Earnings Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Coca Cola Femsa (10/27/2026)Baker Hughes (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
